XML 51 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Expense
Stock based compensation expense for the years ended December 31, 2017, 2016 and 2015 was as follows (in millions):
 
2017
 
2016
 
2015
Stock based compensation
$
83.1

 
$
78.8

 
$
61.8

Tax benefit recognized in net earnings
29.1

 
27.6

 
21.6

Windfall tax benefit, net

 

 
22.2

Weighted-Average Assumptions of Stock-Based Compensation
The weighted-average fair value of options granted in 2017, 2016 and 2015 were calculated using the following weighted-average assumptions:
 
2017
 
2016
 
2015
Weighted-average fair value ($)
40.87

 
34.57

 
33.98

Risk-free interest rate (%)
2.03

 
1.44

 
1.53

Average expected option life (years)
5.26

 
5.20

 
5.10

Expected volatility (%)
18.74

 
21.35

 
22.17

Expected dividend yield (%)
0.67

 
0.70

 
0.62

Stock-Based Compensation Activity
The following table summarizes the Company's activities with respect to its share-based compensation plans for the years ended December 31, 2017 and 2016:
 
Number of shares
 
Weighted-average
exercise price
per share
 
Weighted-average
contractual term
 
Aggregate intrinsic
value
Outstanding at January 1, 2016
3,117,616

 
$
104.54

 
 
 
 
Granted
743,250

 
172.23

 
 
 
 
Exercised
(371,853
)
 
75.23

 
 
 
 
Canceled
(69,416
)
 
159.97

 
 
 
 
Outstanding at December 31, 2016
3,419,597

 
121.31

 
6.15
 
$
211,369,740

Granted
608,598

 
210.56

 
 
 
 

Exercised
(644,610
)
 
95.14

 
 
 
 

Canceled
(187,721
)
 
170.75

 
 
 
 

Outstanding at December 31, 2017
3,195,864


140.68

 
6.09
 
$
368,589,147

Exercisable at December 31, 2017
1,766,869

 
$
103.48

 
4.12
 
$
269,474,477

Schedule of Stock-Based Compensation by Exercise Price Range
The following table summarizes information for stock options outstanding at December 31, 2017:
 
 
Outstanding options
 
Exercisable options
Exercise price
 
Number
 
Average
exercise
price
 
Average remaining
life (years)
 
Number
 
Average
exercise
price
$40.57 - 52.37
 
147,840

 
$
47.38

 
1.7
 
147,840

 
$
47.38

52.37 - 78.56
 
500,259

 
61.18

 
1.2
 
500,259

 
61.18

78.56 - 104.75
 
172,777

 
93.83

 
4.1
 
172,777

 
93.83

104.75 - 130.94
 
342,805

 
117.51

 
5.2
 
342,805

 
117.51

130.94 - 157.12
 
481,652

 
139.21

 
6.4
 
430,101

 
138.27

157.12 - 183.31
 
870,883

 
169.61

 
7.8
 
151,337

 
166.74

183.31 - 209.50
 
225,450

 
187.64

 
8.7
 
21,750

 
185.47

209.50 - 235.68
 
434,398

 
215.02

 
9.3
 

 

235.68 - 261.87
 
19,800

 
253.01

 
9.8
 

 

$40.57 - 261.87
 
3,195,864

 
$
140.68

 
6.1
 
1,766,869

 
$
103.48

Schedule of Nonvested Restricted Stock Awards Activity
A summary of the Company's nonvested shares activity for 2017 and 2016 is as follows:
 
Number of
shares
 
Weighted-average
grant date
fair value
Nonvested at December 31, 2015
709,275

 
$
146.64

Granted
555,730

 
172.67

Vested
(287,233
)
 
141.27

Forfeited
(25,100
)
 
139.56

Nonvested at December 31, 2016
952,672

 
$
164.62

Granted
410,267

 
205.88

Vested
(387,452
)
 
155.95

Forfeited
(116,491
)
 
173.53

Nonvested at December 31, 2017
858,996

 
$
187.01